Matches in SemOpenAlex for { <https://semopenalex.org/work/W2183698352> ?p ?o ?g. }
Showing items 1 to 57 of
57
with 100 items per page.
- W2183698352 abstract "Alprazolam immediate release (IR) tablets are currently approved for the management of anxiety disorder or the short-term relief of symptoms of anxiety. A sublingual (SL) formulation of alprazolam, which disintegrates in the mouth without the need for additional fluids, has been developed. The aim of this study was to determine if the alprazolam SL 1 mg tablet was bioequivalent to the alprazolam IR 1 mg tablet in healthy volunteers. In this randomized, open label, two-way crossover, single dose study, subjects were randomized to receive a single alprazolam 1 mg IR tablet during one dosing period and a single 1 mg SL tablet during the other dosing period. The primary pharmacokinetic endpoints were area under the plasma concentration-time profile from time zero to the time of the last quantifiable concentration AUC (0-t) and maximum plasma concentration (C max ). Adverse events (AEs) were monitored throughout the study. Bioequivalence was concluded if the 90% confidence intervals (CI) for the ratio of adjusted geometric means for both AUC (0-t) and C max were wholly within 80%-125%. Participants were mostly male (27/28 [96.4%]) and had a mean (standard deviation) age of 35.9 (8.2) years. For the alprazolam 1 mg SL tablet relative to the alprazolam 1 mg IR tablet, the ratio of adjusted geometric means (90% CI) for AUC (0-t) and C max were 95.43% (91.74%, 99.27%) and 88.27% (83.68%, 93.11%), respectively. The incidence of AEs was similar during both treatment periods: 24 participants reported 39 AEs during the alprazolam 1 mg IR treatment period, and 23 participants reported 38 AEs during the alprazolam 1 mg SL treatment period. Bioequivalence was demonstrated between the alprazolam IR and SL 1 mg tablets, suggesting that the clinical performance of the SL tablet will be similar to that of the IR tablet." @default.
- W2183698352 created "2016-06-24" @default.
- W2183698352 creator A5017481574 @default.
- W2183698352 date "2013-01-01" @default.
- W2183698352 modified "2023-10-05" @default.
- W2183698352 title "Bioequivalence of Alprazolam Sublingual Tablet Formulation and Alprazolam Immediate Release Tablet in Healthy Volunteers" @default.
- W2183698352 cites W1490716924 @default.
- W2183698352 cites W2027288964 @default.
- W2183698352 cites W2038898066 @default.
- W2183698352 cites W2094468003 @default.
- W2183698352 cites W36420567 @default.
- W2183698352 cites W9622020 @default.
- W2183698352 doi "https://doi.org/10.4172/jbb.1000150" @default.
- W2183698352 hasPublicationYear "2013" @default.
- W2183698352 type Work @default.
- W2183698352 sameAs 2183698352 @default.
- W2183698352 citedByCount "4" @default.
- W2183698352 countsByYear W21836983522014 @default.
- W2183698352 countsByYear W21836983522015 @default.
- W2183698352 countsByYear W21836983522016 @default.
- W2183698352 countsByYear W21836983522020 @default.
- W2183698352 crossrefType "journal-article" @default.
- W2183698352 hasAuthorship W2183698352A5017481574 @default.
- W2183698352 hasBestOaLocation W21836983521 @default.
- W2183698352 hasConcept C118552586 @default.
- W2183698352 hasConcept C181389837 @default.
- W2183698352 hasConcept C2777196872 @default.
- W2183698352 hasConcept C42404028 @default.
- W2183698352 hasConcept C558461103 @default.
- W2183698352 hasConcept C71924100 @default.
- W2183698352 hasConcept C98274493 @default.
- W2183698352 hasConceptScore W2183698352C118552586 @default.
- W2183698352 hasConceptScore W2183698352C181389837 @default.
- W2183698352 hasConceptScore W2183698352C2777196872 @default.
- W2183698352 hasConceptScore W2183698352C42404028 @default.
- W2183698352 hasConceptScore W2183698352C558461103 @default.
- W2183698352 hasConceptScore W2183698352C71924100 @default.
- W2183698352 hasConceptScore W2183698352C98274493 @default.
- W2183698352 hasIssue "04" @default.
- W2183698352 hasLocation W21836983521 @default.
- W2183698352 hasOpenAccess W2183698352 @default.
- W2183698352 hasPrimaryLocation W21836983521 @default.
- W2183698352 hasRelatedWork W1985398792 @default.
- W2183698352 hasRelatedWork W2017999632 @default.
- W2183698352 hasRelatedWork W2107328892 @default.
- W2183698352 hasRelatedWork W2131438589 @default.
- W2183698352 hasRelatedWork W2333271364 @default.
- W2183698352 hasRelatedWork W2388485415 @default.
- W2183698352 hasRelatedWork W2408787368 @default.
- W2183698352 hasRelatedWork W3204382284 @default.
- W2183698352 hasRelatedWork W52917832 @default.
- W2183698352 hasRelatedWork W2186124603 @default.
- W2183698352 hasVolume "05" @default.
- W2183698352 isParatext "false" @default.
- W2183698352 isRetracted "false" @default.
- W2183698352 magId "2183698352" @default.
- W2183698352 workType "article" @default.